Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1990 2
1991 1
1992 2
1993 2
1994 2
1997 4
1999 1
2001 1
2005 1
2014 1
2015 5
2016 7
2017 2
2018 1
2019 1
2021 3
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
The evolution of the Galápagos mantle plume.
Soderman CR, Shorttle O, Gazel E, Geist DJ, Matthews S, Williams HM. Soderman CR, et al. Sci Adv. 2023 Mar 10;9(10):eadd5030. doi: 10.1126/sciadv.add5030. Epub 2023 Mar 10. Sci Adv. 2023. PMID: 36897953 Free PMC article.
Ustekinumab treatment in ulcerative colitis: Real-world data from the Swedish inflammatory bowel disease quality register.
Thunberg J, Björkqvist O, Hedin CRH, Forss A, Söderman C, Bergemalm D; SWIBREG Study Group; Olén O, Hjortswang H, Strid H, Ludvigsson JF, Eriksson C, Halfvarson J. Thunberg J, et al. Among authors: soderman c. United European Gastroenterol J. 2022 Sep;10(7):631-639. doi: 10.1002/ueg2.12275. Epub 2022 Jul 14. United European Gastroenterol J. 2022. PMID: 35834389 Free PMC article.
Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study.
Visuri I, Eriksson C, Karlqvist S, Lykiardopoulos B, Karlén P, Grip O, Söderman C, Almer S, Hertervig E, Marsal J, Malmgren C, Delin J, Strid H, Sjöberg M, Bergemalm D, Hjortswang H, Halfvarson J. Visuri I, et al. Among authors: soderman c. Therap Adv Gastroenterol. 2023 May 30;16:17562848231174953. doi: 10.1177/17562848231174953. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 37274297 Free PMC article.
Ustekinumab Is Associated with Real-World Long-Term Effectiveness and Improved Health-Related Quality of Life in Crohn's Disease.
Forss A, Clements M, Myrelid P, Strid H, Söderman C, Wagner A, Andersson D, Hjelm F; PROSE SWIBREG study group; Olén O, Halfvarson J, Ludvigsson JF. Forss A, et al. Among authors: soderman c. Dig Dis Sci. 2023 Jan;68(1):65-76. doi: 10.1007/s10620-022-07501-z. Epub 2022 Apr 22. Dig Dis Sci. 2023. PMID: 35459973 Free PMC article.
Prospective observational study on Stelara (ustekinumab) assessing effectiveness in Crohn's disease (PROSE): a 16-week follow-up.
Forss A, Clements M, Myrelid P, Strid H, Söderman C, Wagner A, Andersson D, Hjelm F; PROSE SWIBREG study group; Olén O, Ludvigsson JF, Halfvarson J. Forss A, et al. Among authors: soderman c. Scand J Gastroenterol. 2021 Jun;56(6):680-686. doi: 10.1080/00365521.2021.1906946. Epub 2021 Apr 1. Scand J Gastroenterol. 2021. PMID: 33794731 Free article.
Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study.
Eriksson C, Rundquist S, Lykiardopoulos V, Udumyan R, Karlén P, Grip O, Söderman C, Almer S, Hertervig E, Marsal J, Gunnarsson J, Malmgren C, Delin J, Strid H, Sjöberg M, Öberg D, Bergemalm D, Hjortswang H, Halfvarson J; SWIBREG SVEAH Study Group. Eriksson C, et al. Among authors: soderman c. Therap Adv Gastroenterol. 2021 Jul 3;14:17562848211023386. doi: 10.1177/17562848211023386. eCollection 2021. Therap Adv Gastroenterol. 2021. PMID: 34276808 Free PMC article.
37 results